These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35135230)

  • 1. Elevated expression of the MYB proto-oncogene like 2 (MYBL2)-encoding gene as a prognostic and predictive biomarker in human cancers.
    Xin Z; Li Y; Meng L; Dong L; Ren J; Men J
    Math Biosci Eng; 2022 Jan; 19(2):1825-1842. PubMed ID: 35135230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High MYBL2 expression and transcription regulatory activity is associated with poor overall survival in patients with hepatocellular carcinoma.
    Guan Z; Cheng W; Huang D; Wei A
    Curr Res Transl Med; 2018 Mar; 66(1):27-32. PubMed ID: 29274707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-cancer analysis indicates that MYBL2 is associated with the prognosis and immunotherapy of multiple cancers as an oncogene.
    Chen X; Lu Y; Yu H; Du K; Zhang Y; Nan Y; Huang Q
    Cell Cycle; 2021 Nov; 20(21):2291-2308. PubMed ID: 34585645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53.
    Calvisi DF; Simile MM; Ladu S; Frau M; Evert M; Tomasi ML; Demartis MI; Daino L; Seddaiu MA; Brozzetti S; Feo F; Pascale RM
    Hepatology; 2011 Apr; 53(4):1226-36. PubMed ID: 21480327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High expression of MYBL2 promotes progression and predicts a poor survival outcome of prostate cancer].
    Yang M; Zhu X; Shen Y; He Q; Qin Y; Shao Y; Yuan L; Ye H
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1109-1118. PubMed ID: 36073208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
    Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
    J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYBL2 amplification in breast cancer: Molecular mechanisms and therapeutic potential.
    Bayley R; Ward C; Garcia P
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188407. PubMed ID: 32853735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH.
    Xiong YC; Wang J; Cheng Y; Zhang XY; Ye XQ
    Mol Cell Biochem; 2020 May; 468(1-2):185-193. PubMed ID: 32200471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYBL2 (B-MYB) in cervical cancer: putative biomarker.
    Astbury K; McEvoy L; Brian H; Spillane C; Sheils O; Martin C; O'Leary JJ
    Int J Gynecol Cancer; 2011 Feb; 21(2):206-12. PubMed ID: 21270603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma.
    Zhang X; Lv QL; Huang YT; Zhang LH; Zhou HH
    J Exp Clin Cancer Res; 2017 Aug; 36(1):105. PubMed ID: 28784180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma.
    Le L; Luo J; Wu H; Chen L; Tang X; Fu F
    Eur J Histochem; 2021 Mar; 65(2):. PubMed ID: 33782625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYBL2 Is Targeted by miR-143-3p and Regulates Breast Cancer Cell Proliferation and Apoptosis.
    Chen J; Chen X
    Oncol Res; 2018 Jul; 26(6):913-922. PubMed ID: 29268817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA LINC01139 promotes the progression of hepatocellular carcinoma by upregulating MYBL2 via competitively binding to miR-30 family.
    Li ZB; Chu HT; Jia M; Li L
    Biochem Biophys Res Commun; 2020 May; 525(3):581-588. PubMed ID: 32115147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYB proto-oncogene like 2 promotes hepatocellular carcinoma growth and glycolysis via binding to the
    Liu M; Du Q; Mao G; Dai N; Zhang F
    Bioengineered; 2022 Mar; 13(3):5344-5356. PubMed ID: 35176941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma.
    Fujii K; Murase T; Beppu S; Saida K; Takino H; Masaki A; Ijichi K; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Inagaki H
    Histopathology; 2017 Nov; 71(5):823-834. PubMed ID: 28594149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma.
    Yu R; Li C; Lin X; Chen Q; Li J; Song L; Lin L; Liu J; Zhang Y; Kong W; Ouyang X; Chen X
    Pathol Res Pract; 2017 Aug; 213(8):964-968. PubMed ID: 28559119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYBL2 promotes proliferation and metastasis of bladder cancer through transactivation of CDCA3.
    Liu W; Shen D; Ju L; Zhang R; Du W; Jin W; Xiong K; Wang G; Qian K; Zhang Y; Xiao Y; Wang X
    Oncogene; 2022 Oct; 41(41):4606-4617. PubMed ID: 36071275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYBL2 in synergy with CDC20 promotes the proliferation and inhibits apoptosis of gastric cancer cells.
    Deng Q; Wu L; Li Y; Zou L
    Adv Clin Exp Med; 2021 Sep; 30(9):957-966. PubMed ID: 34358419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial transcriptional regulation of HEB/ZEB1/ASCL1 and MYBL2 on Ras/ErbB signaling.
    Zhong F; Chen T; Li B
    Biochem Biophys Res Commun; 2022 Sep; 622():170-176. PubMed ID: 35932528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse prognostic value of MYBL2 overexpression and association with microRNA-30 family in acute myeloid leukemia patients.
    Fuster O; Llop M; Dolz S; García P; Such E; Ibáñez M; Luna I; Gómez I; López M; Cervera J; Montesinos P; Moscardó F; Cordón L; Solves P; de Juan I; Palanca S; Bolufer P; Sanz MÁ; Barragán E
    Leuk Res; 2013 Dec; 37(12):1690-6. PubMed ID: 24199710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.